Last reviewed · How we verify
d-Amphetamine Transdermal Patch
At a glance
| Generic name | d-Amphetamine Transdermal Patch |
|---|---|
| Also known as | d-Amphetamine, Amphetamine |
| Sponsor | Noven Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD (PHASE2)
- Irritation and Sensitization Study of d-Amphetamine Transdermal System (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |